Russell Investments Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-25,140
| Closed | -$364K | – | 4423 |
|
|
2026
Q1 | $364K | Sell |
25,140
-49,033
| -66% | -$703K | ﹤0.01% | 2622 |
|
|
2025
Q4 | $1.06M | Sell |
74,173
-50,445
| -40% | -$496K | ﹤0.01% | 2200 |
|
|
2025
Q3 | $982K | Buy |
124,618
+6,383
| +5% | +$45.4K | ﹤0.01% | 2211 |
|
|
2025
Q2 | $677K | Sell |
118,235
-24,334
| -17% | -$157K | ﹤0.01% | 2229 |
|
|
2025
Q1 | $1.16M | Buy |
142,569
+89,287
| +168% | +$826K | ﹤0.01% | 1967 |
|
|
2024
Q4 | $502K | Buy |
53,282
+44,945
| +539% | +$467K | ﹤0.01% | 2267 |
|
|
2024
Q3 | $89K | Sell |
8,337
-2,046
| -20% | -$22.3K | ﹤0.01% | 2681 |
|
|
2024
Q2 | $103K | Buy |
10,383
+9,860
| +1,885% | +$101K | ﹤0.01% | 2624 |
|
|
2024
Q1 | $6.16K | Buy |
523
+447
| +588% | +$5.72K | ﹤0.01% | 2911 |
|
|
2023
Q4 | $1.08K | Sell |
76
-5,499
| -99% | -$62.4K | ﹤0.01% | 3056 |
|
|
2023
Q3 | $66.2K | Sell |
5,575
-984
| -15% | -$12.7K | ﹤0.01% | 2705 |
|
|
2023
Q2 | $82.4K | Sell |
6,559
-13,397
| -67% | -$159K | ﹤0.01% | 2636 |
|
|
2023
Q1 | $221K | Buy |
19,956
+18,478
| +1,250% | +$228K | ﹤0.01% | 2458 |
|
|
2022
Q4 | $18K | Hold |
1,478
| – | – | ﹤0.01% | 2806 |
|
|
2022
Q3 | $15K | Sell |
1,478
-248
| -14% | -$2.76K | ﹤0.01% | 2834 |
|
|
2022
Q2 | $18K | Sell |
1,726
-944
| -35% | -$7.77K | ﹤0.01% | 2807 |
|
|
2022
Q1 | $25K | Sell |
2,670
-323,193
| -99% | -$3.03M | ﹤0.01% | 2671 |
|
|
2021
Q4 | $3.76M | Sell |
325,863
-101,884
| -24% | -$1.14M | 0.01% | 1430 |
|
|
2021
Q3 | $4.08M | Sell |
427,747
-30,377
| -7% | -$311K | 0.01% | 1368 |
|
|
2021
Q2 | $4.41M | Buy |
458,124
+253,009
| +123% | +$2.47M | 0.01% | 1434 |
|
|
2021
Q1 | $2.02M | Sell |
205,115
-63,148
| -24% | -$977K | ﹤0.01% | 1872 |
|
|
2020
Q4 | $6.19M | Buy |
268,263
+23,783
| +10% | +$486K | 0.01% | 1121 |
|
|
2020
Q3 | $3.45M | Buy |
244,480
+39,582
| +19% | +$577K | 0.01% | 1351 |
|
|
2020
Q2 | $3.09M | Sell |
204,898
-79,212
| -28% | -$965K | 0.01% | 1380 |
|
|
2020
Q1 | $2.63M | Sell |
284,110
-80,600
| -22% | -$766K | 0.01% | 1319 |
|
|
2019
Q4 | $3.55M | Buy |
364,710
+160,808
| +79% | +$1.47M | 0.01% | 1418 |
|
|
2019
Q3 | $1.64M | Buy |
+203,902
| New | +$2.21M | ﹤0.01% | 1785 |
|
|
2018
Q4 | – | Sell |
-13,655
| Closed | -$166K | – | 2956 |
|
|
2018
Q3 | $166K | Sell |
13,655
-33,410
| -71% | -$467K | ﹤0.01% | 2681 |
|
|
2018
Q2 | $735K | Sell |
47,065
-471
| -1% | -$7.12K | ﹤0.01% | 2272 |
|
|
2018
Q1 | $714K | Sell |
47,536
-34,487
| -42% | -$525K | ﹤0.01% | 2352 |
|
|
2017
Q4 | $1.21M | Sell |
82,023
-52,675
| -39% | -$724K | ﹤0.01% | 2058 |
|
|
2017
Q3 | $2.03M | Buy |
134,698
+21,215
| +19% | +$281K | ﹤0.01% | 1769 |
|
|
2017
Q2 | $1.14M | Sell |
113,483
-7,855
| -6% | -$63.2K | ﹤0.01% | 2042 |
|
|
2017
Q1 | $865K | Buy |
121,338
+110,356
| +1,005% | +$698K | ﹤0.01% | 2176 |
|
|
2016
Q4 | $54K | Buy |
+10,982
| New | +$76K | ﹤0.01% | 2968 |
|
Other funds holding FOLD
Russell Investments Group's FOLD Position: Q2 2026 in Review
Russell Investments Group sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 25,140 shares — an estimated $364K sold.
Russell Investments Group first reported a position in FOLD in Q4 2016 and held it in 35 quarters. The position peaked at $6.19M in Q4 2020. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.
- Russell Investments Group reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Russell Investments Group sold 25,140 Amicus Therapeutics shares in Q2 2026, an estimated $364K.
- Russell Investments Group first reported a position in Amicus Therapeutics in Q4 2016 and held it in 35 quarters.
- Russell Investments Group's Amicus Therapeutics position peaked at $6.19M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.